CVS Health EBITDA Margin 2010-2025 | CVS
Current and historical EBITDA (Earnings Before Interest, Taxes, Depreciation and Amortization) margin for CVS Health (CVS) over the last 10 years. The current EBITDA margin for CVS Health as of June 30, 2025 is .
| CVS Health EBITDA Margin Historical Data | |||
|---|---|---|---|
| Date | TTM Revenue | TTM EBITDA | EBITDA Margin |
| 2025-06-30 | $386.64B | $13.59B | 3.51% |
| 2025-03-31 | $378.96B | $14.23B | 3.76% |
| 2024-12-31 | $372.81B | $13.11B | 3.52% |
| 2024-09-30 | $368.91B | $14.11B | 3.82% |
| 2024-06-30 | $363.25B | $16.93B | 4.66% |
| 2024-03-31 | $360.94B | $17.07B | 4.73% |
| 2023-12-31 | $357.78B | $18.11B | 5.06% |
| 2023-09-30 | $347.81B | $18.30B | 5.26% |
| 2023-06-30 | $339.20B | $10.62B | 3.13% |
| 2023-03-31 | $330.92B | $12.03B | 3.64% |
| 2022-12-31 | $322.47B | $12.18B | 3.78% |
| 2022-09-30 | $315.23B | $10.91B | 3.46% |
| 2022-06-30 | $307.86B | $18.41B | 5.98% |
| 2022-03-31 | $299.84B | $18.12B | 6.04% |
| 2021-12-31 | $292.11B | $18.23B | 6.24% |
| 2021-09-30 | $285.06B | $18.46B | 6.47% |
| 2021-06-30 | $278.32B | $18.19B | 6.54% |
| 2021-03-31 | $271.05B | $18.51B | 6.83% |
| 2020-12-31 | $268.71B | $18.35B | 6.83% |
| 2020-09-30 | $266.04B | $18.82B | 7.07% |
| 2020-06-30 | $263.80B | $18.48B | 7.01% |
| 2020-03-31 | $261.89B | $17.10B | 6.53% |
| 2019-12-31 | $256.78B | $16.36B | 6.37% |
| 2019-09-30 | $244.31B | $16.08B | 6.58% |
| 2019-06-30 | $226.99B | $15.26B | 6.72% |
| 2019-03-31 | $210.48B | $14.05B | 6.67% |
| 2018-12-31 | $194.58B | $12.89B | 6.62% |
| 2018-09-30 | $188.56B | $12.83B | 6.80% |
| 2018-06-30 | $187.25B | $12.75B | 6.81% |
| 2018-03-31 | $186.02B | $12.43B | 6.68% |
| 2017-12-31 | $184.79B | $12.20B | 6.60% |
| 2017-09-30 | $182.37B | $12.05B | 6.61% |
| 2017-06-30 | $180.81B | $12.37B | 6.84% |
| 2017-03-31 | $178.85B | $12.47B | 6.97% |
| 2016-12-31 | $177.55B | $12.86B | 7.24% |
| 2016-09-30 | $172.70B | $12.55B | 7.26% |
| 2016-06-30 | $166.73B | $11.97B | 7.18% |
| 2016-03-31 | $160.17B | $11.75B | 7.33% |
| 2015-12-31 | $153.29B | $11.57B | 7.55% |
| 2015-09-30 | $149.20B | $11.05B | 7.40% |
| 2015-06-30 | $145.58B | $10.91B | 7.49% |
| 2015-03-31 | $143.01B | $10.85B | 7.59% |
| 2014-12-31 | $139.37B | $10.73B | 7.70% |
| 2014-09-30 | $135.14B | $10.60B | 7.84% |
| 2014-06-30 | $132.05B | $10.49B | 7.94% |
| 2014-03-31 | $128.70B | $10.21B | 7.93% |
| 2013-12-31 | $126.76B | $9.91B | 7.82% |
| 2013-09-30 | $125.31B | $9.97B | 7.96% |
| 2013-06-30 | $123.61B | $9.61B | 7.78% |
| 2013-03-31 | $123.07B | $9.33B | 7.58% |
| 2012-12-31 | $123.12B | $8.96B | 7.28% |
| 2012-09-30 | $120.04B | $8.58B | 7.15% |
| 2012-06-30 | $116.48B | $8.31B | 7.13% |
| 2012-03-31 | $112.18B | $8.05B | 7.17% |
| 2011-12-31 | $107.08B | $7.90B | 7.38% |
| 2011-09-30 | $103.08B | $7.67B | 7.44% |
| 2011-06-30 | $100.12B | $7.52B | 7.51% |
| 2011-03-31 | $97.71B | $7.52B | 7.69% |
| 2010-12-31 | $95.78B | $7.61B | 7.94% |
| 2010-09-30 | $96.79B | $7.72B | 7.98% |
| 2010-06-30 | $97.72B | $7.74B | 7.92% |
| 2010-03-31 | $98.58B | $7.85B | 7.96% |
| 2009-12-31 | $98.22B | $7.81B | 7.96% |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Services | $91.231B | $372.809B |
| CVS Health Corporation is a pharmacy innovation company. Its offerings include pharmacy benefit management services, mail order, retail and specialty pharmacy, disease management programs, and retail clinics. The Company serves employers, insurance companies, unions, government employee groups, managed care organizations and other sponsors of health benefit plans, and individuals under the CVS Caremark Pharmacy Services, Caremark, CVS Caremark, CarePlus CVS/pharmacy, RxAmerica, Accordant, SilverScript, and Novologix names. CVS Health Corporation, formerly known as CVS Caremark Corporation, is headquartered in Woonsocket, Rhode Island. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Danaher (DHR) | United States | $146.791B | 27.22 |
| Elevance Health (ELV) | United States | $69.762B | 9.38 |
| Cencora (COR) | United States | $56.333B | 18.76 |
| DiDi Global (DIDIY) | China | $26.403B | 28.05 |
| Labcorp Holdings (LH) | United States | $23.210B | 18.45 |
| Natera (NTRA) | United States | $22.377B | 0.00 |
| BioMerieux (BMXMF) | France | $17.423B | 0.00 |
| EUROFINS SCIENT (ERFSF) | Luxembourg | $14.898B | 0.00 |
| ICON (ICLR) | Ireland | $14.052B | 13.52 |
| Medpace Holdings (MEDP) | United States | $13.301B | 35.20 |
| CochLear (CHEOY) | Australia | $12.977B | 0.00 |
| Solventum (SOLV) | United States | $12.638B | 13.04 |
| Viatris (VTRS) | United States | $12.148B | 4.32 |
| Caris Life Sciences,�Inc (CAI) | United States | $10.748B | 0.00 |
| Revvity (RVTY) | United States | $10.283B | 18.12 |
| Avantor (AVTR) | United States | $8.992B | 13.19 |
| Charles River Laboratories (CRL) | United States | $8.012B | 15.20 |
| Sonic Healthcare (SKHHY) | Australia | $7.799B | 0.00 |
| HealthEquity (HQY) | United States | $7.608B | 33.33 |
| Bausch + Lomb (BLCO) | Canada | $5.151B | 34.64 |
| Sotera Health (SHC) | United States | $4.687B | 26.19 |
| BrightSpring Health Services (BTSG) | United States | $4.239B | 32.34 |
| Amplifon S.p.A (AMFPF) | Italy | $3.937B | 21.83 |
| GeneDx Holdings (WGS) | United States | $3.711B | 84.99 |
| Alignment Healthcare (ALHC) | United States | $3.196B | 0.00 |
| Concentras Parent (CON) | United States | $2.993B | 18.98 |
| Surgery Partners (SGRY) | United States | $2.926B | 36.81 |
| Organon (OGN) | United States | $2.392B | 2.61 |
| KindlyMD (NAKA) | United States | $2.377B | 0.00 |
| Premier (PINC) | United States | $2.161B | 20.04 |
| Progyny (PGNY) | United States | $1.979B | 41.85 |
| Ardent Health (ARDT) | United States | $1.819B | 7.02 |
| PACS (PACS) | United States | $1.807B | 0.00 |
| GoodRx Holdings (GDRX) | United States | $1.564B | 26.47 |
| Pediatrix Medical (MD) | United States | $1.496B | 9.99 |
| Teladoc Health (TDOC) | United States | $1.368B | 0.00 |
| Omada Health (OMDA) | $1.343B | 0.00 | |
| Establishment Labs Holdings (ESTA) | $1.230B | 0.00 | |
| Ryman Healthcare (RYHTY) | New Zealand | $0.962B | 0.00 |
| Embecta (EMBC) | United States | $0.853B | 5.00 |
| AMN Healthcare Services Inc (AMN) | United States | $0.771B | 9.53 |
| CareDx (CDNA) | United States | $0.707B | 13.03 |
| Performant Healthcare (PHLT) | United States | $0.599B | 0.00 |
| QDM (QDMI) | Hong Kong, SAR China | $0.583B | 100.00 |
| Agilon Health (AGL) | United States | $0.539B | 0.00 |
| InnovAge Holding (INNV) | United States | $0.535B | 0.00 |
| Nutex Health (NUTX) | United States | $0.499B | 7.55 |
| Sonida Senior Living (SNDA) | United States | $0.493B | 0.00 |
| Auna S.A (AUNA) | Luxembourg | $0.466B | 6.99 |
| COMPASS Pathways (CMPS) | United Kingdom | $0.453B | 0.00 |
| SBC Medicals (SBC) | United States | $0.434B | 9.50 |
| Enhabit (EHAB) | United States | $0.406B | 26.67 |
| So-Young (SY) | China | $0.399B | 0.00 |
| Oncology Institute (TOI) | United States | $0.324B | 0.00 |
| LifeMD (LFMD) | United States | $0.304B | 0.00 |
| Beauty Health (SKIN) | United States | $0.260B | 0.00 |
| Shoulder Innovations (SI) | United States | $0.240B | 0.00 |
| DocGo (DCGO) | United States | $0.158B | 0.00 |
| Ascend Wellness Holdings (AAWH) | United States | $0.158B | 0.00 |
| Sera Prognostics (SERA) | United States | $0.107B | 0.00 |
| Biodesix (BDSX) | United States | $0.069B | 0.00 |
| NeueHealth (NEUE) | United States | $0.060B | 0.00 |
| IceCure Medical (ICCM) | Israel | $0.058B | 0.00 |
| NeuroOne Medical Technologies (NMTC) | United States | $0.038B | 0.00 |
| Basel Medical Group (BMGL) | Singapore | $0.036B | 0.00 |
| SeaStar Medical Holding (ICU) | United States | $0.024B | 0.00 |
| OSR Holdings (OSRH) | United States | $0.019B | 0.00 |
| Intelligent Bio Solutions (INBS) | United States | $0.014B | 0.00 |
| Co-Diagnostics (CODX) | United States | $0.013B | 0.00 |
| BioNexus Gene Lab (BGLC) | $0.010B | 0.00 | |
| ModivCare (MODV) | United States | $0.006B | 0.00 |
| XWELL (XWEL) | United States | $0.006B | 0.00 |
| Pheton Holdings (PTHL) | China | $0.005B | 0.00 |
| INVO Fertility (IVF) | United States | $0.004B | 0.00 |
| Aclarion (ACON) | United States | $0.004B | 0.00 |
| ISpecimen (ISPC) | United States | $0.004B | 0.00 |
| NewGenIvf Group (NIVF) | Thailand | $0.002B | 0.00 |
| Cano Health (CANOQ) | United States | $0.000B | 0.00 |